Rejuvenation of Premature Ovarian Failure With Stem Cells (ROSE-1)
Autologous Stem Cell Therapy for Premature Ovarian Insufficiency and Low Ovarian Reserve
The University of Illinois at Chicago is conducting a trial of a treatment for Premature Ovarian Failure (POF) with bone marrow-derived stem cells from the patient’s own body. They are seeking female patients who have a diagnosis of premature ovarian insufficiency who are or would like to achieve pregnancy.
Under anaesthesia, the participants will receive an injection of the stem cells to the right ovary. After treatment, hormone levels, normal menses, and achievement of pregnancy will be followed for 12 months.
- Be 18 years of age and older and female
- Have a diagnosis of premature ovarian insufficiency
- Meet screening criteria regarding ovarian anatomy
- Be planning and/or willing to attempt to get pregnant as part of the protocol
THE STUDY INVOLVES:
- Prescreening tests to confirm eligibility of the patient to participate.
- Recovery of the bone marrow aspirate and injection to the right ovary of stem cells isolated from it.
- After treatment, hormone levels, normal menses, and achievement of pregnancy will be followed for 12 months.
LOCATIONS AND CONTACTS:
The study site is at the University of Illinois at Chicago. Map.
Ashley McHugh | 312-355-1385 | [email protected]
Riddhi Vyas | 312-996-2348 | [email protected]
University of Illinois at Chicago
Or go online: